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Edited by Robert B. RussellAbstract The CLN3 gene encodes an integral membrane pro-
tein of unknown function. Mutations in CLN3 can cause juvenile
neuronal ceroid lipofuscinosis, or Batten disease, an inherited
neurodegenerative lysosomal storage disease aﬀecting children.
Here, we report a topological study of the CLN3 protein using
bioinformatic approaches constrained by experimental data.
Our results suggest that CLN3 has a six transmembrane helix
topology with cytoplasmic N and C-termini, three large lumenal
loops, one of which may contain an amphipathic helix, and one
large cytoplasmic loop. Surprisingly, varied topological predic-
tions were made using diﬀerent subsets of orthologous sequences,
highlighting the challenges still remaining for bioinformatics.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Bioinformatics1. Introduction
Juvenile neuronal ceroid lipofuscinosis (JNCL), or Batten
disease, is a neurodegenerative lysosomal storage disease
aﬀecting children which results from the autosomal recessive
inheritance of mutations in CLN3, a gene encoding a 438 ami-
no acid transmembrane (TM) protein [1]. The function of the
CLN3 protein remains elusive and currently hinders under-
standing of the molecular basis of this fatal disease. Elucidat-
ing the TM topology of CLN3 will give insight to its function
and eventual mechanism of action. Despite several experimen-
tal topology studies using antibodies, inserted tags and glyco-
sylation mutagenesis, it remains controversial.
Previous predicted topological models for CLN3 have pro-
posed between ﬁve and eight TM spanning helices (TMH)
which diﬀer in their placement of the amino terminus on either
side of the membrane [2–4]. The bioinformatic methods used in
these predictions have relied on the physiochemical principle of
a sliding window of hydrophobicity to detect TM helices. Such
methods have since been replaced by machine learning ap-*Corresponding author. Address: MRC-LMCB, UCL, Guilford
Street, London, United Kingdom. Fax: +44 207 679 7805.
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doi:10.1016/j.febslet.2008.02.049proaches including hidden Markov models (e.g. Phobius [5])
and neural networks (e.g. MEMSAT3 [6]), which prevail over
hydrophobicity based methods due to their probabilistic orien-
tation. With prediction accuracy now approaching 80%, we
have used these more sophisticated tools on the protein se-
quence of CLN3 orthologues in many species to produce a
new model for CLN3 topology. This model is in agreement
with almost all published experimental data supporting the
accuracy of these machine learning based topology prediction
methods.2. Materials and methods
We analysed CLN3 sequences using a selection of the highest scor-
ing prediction methods via the PONGO server [7]. Two servers which
allowed constrained predictions to be made, Phobius and HMMTOP
[8], were used with all available experimental constraints except those
relating to the N-terminal region (the N-terminus, residues 1–20 and 1–
33), which are controversial. In addition, MEMSAT3 was used in con-
junction with a database of 50 diverse multi-species CLN3 sequences
from 46 species (Caenorhabditis species have three CLN3 genes) that
had been manually curated (MEMSAT + CLN3), a database of a sub-
set of 40 microbial CLN3 sequences (MEMSAT +Microbial CLN3)
and Swissprot release 54.0 (MEMSAT + Swissprot) in order to pro-
duce PSI-BLAST proﬁles [9] used to enhance the prediction, while
the remaining methods were run using either human or individual
microbial CLN3 sequences. The results are shown in Figs. 1 and 4.
In addition, the ScanPROSITE [10] was used to detect potential phos-
phorylation and N-glycosylation sites, PSI-PRED [11] was used to as-
sess secondary structure and the LIPS (LIPid-facing Surface) server
[12] was used to predict helix–lipid interfaces.3. Results and discussion
Using a selection of prediction methods, a range of diﬀerent
models were produced with between ﬁve and ten TM spanning
helices (Fig. 1). Despite this variation, there are three distinct
regions where there is a unanimous consensus between all pre-
diction methods: amino acid residues 97–121, 210–231 and
276–303. Residues 36–60 show a strong consensus in all except
one method. A multi-species CLN3 alignment of 50 sequences
shows that these four regions are enriched with hydrophobic
residues yet show distinct sequence variation – two features
which are entirely consistent with lipid-exposed membrane-
spanning helices.blished by Elsevier B.V. All rights reserved.
Fig. 1. Results of topology prediction for CLN3 showing models with cytoplasmic amino terminals and between ﬁve and ten TM spanning helices
generated using seven diﬀerent methods, and our consensus prediction that takes into account additional information discussed within the text. The
Kyte–Doolittle plot was generated using a 19 residue sliding window.
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helix in a number of cases. The region 122–209 – a highly
hydrophobic stretch but with no clear peaks of hydrophobicity
– is likely to contain only one TM helix at about 129–153,
roughly in-line with the MEMSAT3 (using Swissprot), Phobi-
us and HMMTOP predictions. A helix in this position allows
for a short loop region after the second helix, and leaves the
highly conserved residues at positions 159–195 exposed on a
loop. The multi-species alignment of CLN3 orthologues indi-
cates this loop contains insertions in a number of species which
casts doubt over the additional TM helices predicted for this
region by three methods.
At position 319–336 there is a discrepancy in the consensus
prediction, with three methods predicting a TM helix and the
remainder predicting a loop. The Kyte–Doolittle plot indicates
this region has relatively low hydrophobicity and it is in fact
enriched with polar residues making it an unlikely candidate
for a TM helix. A PSIPRED secondary structure prediction
does however show a high helix forming propensity for this
stretch, and a bias in hydrophobic residue phasing to one side
is indicated on construction of a helical wheel (Fig. 2). This
suggested to us that the region may form an amphipathic helix
partially buried in the membrane, a model which is further
strengthened by a high lipid exposure score (10.810) for theFig. 2. Sequence comparison of the potential amphipathic helix from selecte
helix is presented as a helical wheel with hydrophobic residues shaded in light
the position of the membrane.buried surface (using the LIPS Server). This orientation would
result in the highly conserved residues Tyr326, Gln327,
Gly329, Val330, Ser333 and Arg334 facing into the lumen
away from the membrane and thus free to interact with poten-
tial binding partners. The two helix surfaces that contain these
residues also score lowest in terms of lipid exposure (2.558 and
2.735).
Between residues 340 and 393 – another highly hydrophobic
region with no clear peaks of hydrophobicity – the general
consensus is that there are two TM helices connected with a
very short loop region. However, we are inclined to accept
the MEMSAT3 (using Swissprot), Phobius and HMMTOP
predictions of one helix spanning 353–375 which uniﬁes the
two predicted by other methods. A single helix in this position
allows the highly conserved ﬂanking residues to be positioned
in loop regions, as is usual, whereas the two-helix predictions
would place both these areas inside the membrane.
Finally, we rule out the last helix, present in four of the six
models, spanning 406–433. This region contains two distinctive
lysosomal sorting motifs [13] that experimentally must reside
in the cytosol.
We thus propose a six TM topology model with cytoplasmic
N- and C-termini, three large lumenal loops, one of which is
likely to contain an amphipathic helix, and one large cytoplas-d species. Numbers refer to amino-acid position in human CLN3. The
grey and polar residues in dark grey. The area below the line illustrates
Table 1
Locations of experimentally determined regions/residues
Region/residue Location Reference
N-terminal Cytoplasmic [15]
1–33 Cytoplasmic [13]
1–20 Lumenal [4,14]
71 Lumenal [16]
67–91 Same as 163-215 Unpublished data cited within [4]
85 Lumenal [16]
163–215 Same as 67-91 Unpublished data cited within [4]
199 Lumenal [4]
250–264 Cytoplasmic [4,14]
242–258 Cytoplasmic [13]
310 Lumenal [4]
321 Lumenal [4]
401 Cytoplasmic [13]
435 Cytoplasmic [16]
C-terminal Cytoplasmic [4], inferred in [13]
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tational approaches for topological predictions of transmem-
brane proteins using their primary sequence, and is
unconstrained. Importantly, this model (Fig. 3) is supported
by almost all experimentally determined terminal and loop
locations (Table 1). The exception is data [4,14] indicating that
the N-terminus might be lumenal, in contrast to independent
data [13,15] which indicate that it is cytoplasmic. This possible
lumenal location for the N-terminus was suggested by (1)
inability to immunoprecipitate translated CLN3 from micro-
somes or expressed on the surface of cells using antisera that
recognised the N-terminus of CLN3 and (2) glycosylation of
CLN3 even when Asn310 was mutated (the remaining putative
glycosylation sites are Asn49, Asn71 and Asn85). We cannot
explain why the immunoprecipitation of CLN3 translated by
microsomes did not occur. However, we can suggest that, pro-
vided Asn71 or Asn85 is glycosylated as shown later [16],
Asn49 does not have to be lumenal.
Additionally, we attempted to construct models of two di-
verse yeast CLN3 sequences [17], Schizosaccharomyces pombe
and Saccharomyces cerevisiae, using 40 microbial CLN3 se-
quences to create PSI-BLAST proﬁles for MEMSAT3. In con-
trast to our human CLN3 model, we found a strong consensus
for up to 11 TMH between all the predictors for both species
(Fig. 4). One of these TM helices (helix 8) corresponds to the
predicted amphipathic helix (Fig. 2), suggesting a 10 TMH
model that also contains an amphipathic helix for these yeast
species (Supplementary Figure 1). Aligning each of the 10
transmembrane helices against the human CLN3 sequence re-
sulted in signiﬁcant scores between only the 1st, 2nd and 5th
helices of our human model and the 1st, 2nd and 7th helices
of the yeast models. However, helices 4 and 5 of the yeast mod-
el contain the most highly conserved residues between all
orthologues (including two residues mutated in disease), mak-
ing it unlikely that they would be present in a membrane in one
species and projecting into the lumen in another. These helices
also contain the equivalent residues to those experimentally
proven to reside in the lumen in human CLN3 (Table 1). Sim-
ilarly helix 10 contains a conserved residue mutated in disease,
and the loop between these helices 9 and 10 is very conservedFig. 3. Schematic model for human CLN3 showing the six transmembrane h
locations (see Table 1).suggesting that it should have the same orientation in yeast and
mammalian species. Our assumption that conserved regions
should have the same topological orientation is consistent with
the knowledge that human CLN3 protein can functionally sub-
stitute for Btn1p in Schizosaccharomyces pombe and Saccharo-
myces cerevisiae [18,19]. CLN3 and its orthologues, then, have
a topology that is not entirely straightforward to predict using
currently available methods. In such a situation, our approach
that makes use of all available sequences to reach a consensus
prediction is even more appropriate. This also explains the dis-
crepancy between MEMSAT3 + Swissprot and MEM-
SAT3 + CLN3 models which were constructed using PSI-
BLAST proﬁles composed predominantly of mammalian and
microbial CLN3 sequences, respectively .
The human model contains 16 positively charged residues in
cytoplasmic loops, compared with only eight in lumenal loops,
which is consistent with the general observation of a more pos-
itively charged cytoplasmic surface – the positive inside rule
[20]. Within the TM region, there are six potentially charged
residues. While this is energetically unfavourable, their spatial
distribution across four TM helices allows for the formation
of ion-pairs between Asp103 (TMH2) and His146 (TMH3),
and Lys112 (TMH2) and Glu295 (TMH5) or Asp362elices, proposed amphipathic helix and experimentally determined loop
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potentials should CLN3 undergo dimerisation. While the for-
mation of either of these salt bridges could help stabilise the
structure, they would also impose constraints on the three-
dimensional folding of the protein. Further stability could be
provided should disulﬁde bridges form between cysteine resi-
dues which are present on two lumenal loops (although these
are not conserved across species), consistent with the expecta-
tions for a correct model in which such bridges usually form
post-synthesis in the oxidative environment of the endoplasmic
reticulum lumen.
CLN3 has been shown to undergo phosphorylation when
incubated with cAMP-dependent protein kinase, cGMP-
dependent protein kinase or casein kinase II [21], though the
speciﬁc residues involved are unknown. Using the ScanPRO-
SITE tool, nine potential phosphorylation sites were detected,
six on cytoplasmic loops (Ser12, Ser14, Thr19, Thr232, Ser270
and Thr400) and three on lumenal loops (Ser69, Ser74 and
Ser86), with the cytoplasmic signatures showing higher conser-
vation on average than those in the lumen. While the PRO-
SITE phosphorylation signatures oﬀer a large degree of
freedom and are thus known to produce high numbers of false
positives, the bias in frequency towards cytoplasmic loops can
be explained by the observation that the kinases responsible
are known to localise exclusively in the cytoplasm [22].
Of the four potential N-glycosylation sites that were pre-
dicted by us (Asn49, Asn71, Asn85 and Asn310), two have
had their locations validated experimentally (Asn71, Asn85),
whilst a discrepancy in concluding that Asn310 is glycosylated
(and hence lumenal) in the native protein may be caused by
diﬀerent experimental strategies [4,16]. These three are cor-
rectly placed on lumenal loops by our model. This bias in fre-
quency towards lumenal loops may be explained by the ability
of glycosylation to prevent proteolysis in the protease-rich
lysosomal lumen, thought to be the reason lysosomal mem-
brane proteins are often heavily glycosylated. Both CLN3
and its yeast orthologues traﬃc to the lysosome/vacuole
[13,18], although this may not be their only functional loca-
tion. The remaining potential N-glycosylation motif has been
placed within the ﬁrst TM helix; however, unlike the other
three, this site has not been validated experimentally and is
most likely a false positive.
CLN3 has orthologues identiﬁed to date in at last 46 diverse
eukaryotic species. Sequence homology extends from residueFig. 4. Results of topology prediction for Schizosaccharomyces pombe Btn1
of 11 TM spanning helices. MEMSAT3 was used in conjunction with a
proﬁles. Predicted helices marked with a dark line are conserved in human
model.41 of the human CLN3 protein in large stretches to the end
of the protein, with certain residues, including most disease-
causing missense mutations (http://www.ucl.ac.uk/ncl/
cln3.shtml), identical or similar across all species. Our model
can be used to examine the topological position of the most
conserved residues and regions. From this several interesting
and striking observations can be made. First, we note that
the N-terminus, the ﬁrst lumenal loop and the second cytoplas-
mic loop of CLN3 are not well conserved across most species,
suggesting that these do not contribute directly to the basic
function of the protein. Second, in contrast, the second and
third lumenal loops and much of the C-terminus are highly
conserved across diverse species, as is the proposed amphi-
pathic helix (contained within the third lumenal loop), suggest-
ing that these regions contribute important structural
constraints or domains important for function or, in the case
of the C-terminus, traﬃcking. All known disease-causing mis-
sense mutations are located either in or immediately adjacent
to a predicted TM helix (Leu101, Glu295 and Gln352) or in
the conserved lumenal loops (Ala158, Leu170 and Gly187) or
the amphipathic helix (Val330 and Arg334 which is mutated
twice) or the C terminus (Asp416) consistent with the impor-
tance of these regions. Of particular interest, the amphipathic
helix is predicted to reside on the lumenal side of the membrane,
as do three of the residues mutated in disease, suggesting that
the role of CLN3 is important within the lumen of intracellular
compartments. Experimental interpretation to date has fa-
voured the mammalian lysosome or yeast vacuole as the likely
site of action, although there is evidence in Sz. pombe that
Btn1p exerts a function from a prevacuolar compartment that
aﬀects vacuole homeostasis [18], and the same may be true for
CLN3 in mammalian cells. In addition, CLN3 has been ob-
served on the plasma membrane [14,16] in which case these do-
mains would be projecting into the extracellular space until
internalisation by endocytosis when they would regain a lume-
nal location. These important residues may interact with lume-
nal molecular species such as proteins, carbohydrate moieties
or the lipid bilayer, or transduce changes in the lumenal envi-
ronment (e.g. pH) to modulate CLN3 activity.
Helices that interact with the lipid bilayer are thought to
modulate the activity of many ion channels [23,24]. The pro-
posed amphipathic helix of CLN3 may act similarly and, if
so, the local composition of the lipid membrane may inﬂuence
function. Intriguingly, two methods suggest CLN3 may be in-p showing models with cytoplasmic amino terminals and a consensus
database of 40 microbial CLN3 sequences to construct PSI-BLAST
and correspond to the 1st, 2nd, 5th and the amphipathic helix of our
T. Nugent et al. / FEBS Letters 582 (2008) 1019–1024 1023volved in transport. FFPred, a protein feature based function
prediction method [25], suggests a role in ion transport, while
Pfam [26] lists CLN3 as a member of the major facilitator
superfamily (MFS) clan, again suggesting a possible role as a
transporter. (Interestingly, the most recently identiﬁed NCL
gene, MFSD8/CLN7 also encodes a member of the MFS
super-family [27].) CLN3 has also been suggested to be a mem-
ber of the equilibrative nucleoside transporter (ENT) family
[28] on the basis of iterative PSI-BLAST searching. However,
careful inspection of global alignments between CLN3 and the
12-TMH members of the MFS family or the 11-TMH mem-
bers of the ENT family suggests these hits may be false posi-
tives, and analysis of CLN3 TM helices fails to identify any
which look to be involved in pore formation. Experiments that
target residues in these regions and deﬁne the phenotypic con-
sequences of mutations may shed light on their role. In addi-
tion, the identiﬁcation of any interacting partners with the
lumenal loops will require specialized biochemical approaches,
since many commonly used methods (e.g. two-hybrid) are only
appropriate for cytoplasmic interactions.
In summary, we propose a six helix TM topology for CLN3,
a novel predicted amphipathic helix previously unrecognized,
with both termini located in the cytoplasm. We have shown
that a consensus approach combined with careful analysis of
evolutionary data can produce a model which agrees with al-
most all published experimental data. Previous work had been
less conﬁdent about the number of possible TM helices,
although one model proposed on the basis of experimental
ﬁndings [13] agrees closely with ours. Our unexpected ﬁnding
that orthologues of CLN3 might produce diﬀerent topologies
highlight the increasing realization that transmembrane topol-
ogy may not be as highly conserved between distantly related
species as previously thought. Taking into account the location
of the conserved residues may help identify the regions critical
for structure or function and this can be used to inform topo-
logical interpretations. Our approach may have wider applica-
bility in the prediction of the topology of other transmembrane
proteins, particularly those containing additional hydrophobic
structures that may not be membrane spanning. Determining
the correct topology of CLN3 is critical for complete under-
standing the mechanism of Batten disease. However, until a
CLN3 crystal structure can reveal the true TM topology in
atomic resolution, likely to be some way beyond current capa-
bilities, a model produced by combining experimental data
with topology prediction provides us with one that can be fur-
ther tested experimentally. Signiﬁcantly, the presence of a lu-
menal amphipathic helix and conserved intralumenal
domains provides new insight into the possible mechanism of
action of CLN3 and its orthologues in model organisms that
can also be investigated appropriately.
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